Latest Insider Positions


Danziger Asaf is listed as an insider in the following companies: NVCR / NovoCure Limited Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Holdings

Security Title Post Shares
NVCR / NovoCure Chief Executive Officer, Director 70,113

Latest Transactions

Latest
Tran Date
Security Code Shares Post Shares Percent
Change
Share
Price
Tran
Value
Post
Value
Percent
Change
2018-07-06 NVCR / NovoCure A 795 70,113 1.15 17.255 13,718
2018-06-27 NVCR / NovoCure S -70,364 69,318 -50.37 32.086 -2,257,699 2,224,137 -101.51
2018-06-20 NVCR / NovoCure S -8,308 139,682 -5.61 32.0351 -266,148 4,474,727 -5.95
2018-06-19 NVCR / NovoCure S -621 147,990 -0.42 32.00 -19,872 4,735,680 -0.42
2018-06-18 NVCR / NovoCure S -22,289 148,611 -13.04 32.00 -713,248 4,755,552 -15.00
2018-06-14 NVCR / NovoCure S -200 170,900 -0.12 32.00 -6,400 5,468,800 -0.12
2018-06-13 NVCR / NovoCure S -11,720 171,100 -6.41 32.00 -375,040 5,475,200 -6.85
2018-06-04 NVCR / NovoCure S -2,800 182,820 -1.51 32.00 -89,600 5,850,240 -1.53
2018-06-04 NVCR / NovoCure S -19,694 185,620 -9.59 31.64 -623,118 5,873,017 -10.61
2018-06-04 NVCR / NovoCure S -28,150 205,314 -12.06 30.34 -854,071 6,229,227 -13.71
2018-06-04 NVCR / NovoCure S -26,782 233,464 -10.29 29.31 -784,980 6,842,830 -11.47
2018-06-04 NVCR / NovoCure S -149,878 260,246 -36.54 28.43 -4,261,032 7,398,794 -57.59
2018-02-22 NVCR / NovoCure M 53,334 410,124 14.95 21.55 1,149,348
2018-01-29 NVCR / NovoCure S -13,974 356,790 -3.77 24.0152 -335,588 8,568,383 -3.92
2018-01-25 NVCR / NovoCure S -6,456 370,764 -1.71 22.4349 -144,840 8,318,053 -1.74
2018-01-24 NVCR / NovoCure S -10,600 377,220 -2.73 22.1705 -235,007 8,363,156 -2.81
2018-01-23 NVCR / NovoCure S -10,248 387,820 -2.57 22.033 -225,794 8,544,838 -2.64
2018-01-16 NVCR / NovoCure S -14,900 398,068 -3.61 22.1983 -330,755 8,836,433 -3.74
2018-01-12 NVCR / NovoCure S -22,895 412,968 -5.25 22.0239 -504,237 9,095,166 -5.54
2018-01-11 NVCR / NovoCure S -313,525 435,863 -41.84 22.3507 -7,007,503 9,741,843 -71.93
2018-01-08 NVCR / NovoCure A 283 749,388 0.04 15.045 4,258
2017-11-06 NVCR / NovoCure S -6,919 749,105 -0.92 22.00 -152,218 16,480,310 -0.92
2017-11-03 NVCR / NovoCure S -2,300 756,024 -0.30 22.00 -50,600 16,632,528 -0.30
2017-11-01 NVCR / NovoCure S -15,716 758,324 -2.03 22.0075 -345,870 16,688,815 -2.07
2017-10-31 NVCR / NovoCure S -150 774,040 -0.02 22.00 -3,300 17,028,880 -0.02
2017-09-25 NVCR / NovoCure S -900 774,190 -0.12 22.05 -19,845 17,070,890 -0.12
2017-09-14 NVCR / NovoCure S -1,772 775,090 -0.23 22.00 -38,984 17,051,980 -0.23
2017-09-13 NVCR / NovoCure S -35,500 776,862 -4.37 22.0146 -781,518 17,102,306 -4.57
2017-07-14 NVCR / NovoCure M 354,780 812,362 77.53 0.38 134,816
2017-07-11 NVCR / NovoCure S -5,183 457,582 -1.12 20.19 -104,645 9,238,581 -1.13
2017-07-11 NVCR / NovoCure S -2,200 462,765 -0.47 19.40 -42,680 8,977,641 -0.48
2017-07-10 NVCR / NovoCure S -203,900 464,965 -30.48 18.077 -3,685,900 8,405,172 -43.85
2017-07-07 NVCR / NovoCure S -70,459 668,865 -9.53 18.034 -1,270,658 12,062,311 -10.53
2017-07-06 NVCR / NovoCure S -5,050 739,324 -0.68 18.088 -91,344 13,372,893 -0.68
2017-07-05 NVCR / NovoCure S -155,088 744,374 -17.24 18.144 -2,813,917 13,505,922 -20.83
2017-07-05 NVCR / NovoCure A 2,545 899,462 0.28 6.673 16,983
2017-06-19 NVCR / NovoCure S -124,720 896,917 -12.21 15.514 -1,934,906 13,914,770 -13.91
2017-06-16 NVCR / NovoCure S -9,212 1,021,637 -0.89 15.018 -138,346 15,342,944 -0.90
2017-06-15 NVCR / NovoCure S -33,245 1,030,849 -3.12 15.187 -504,892 15,655,504 -3.23
2017-06-14 NVCR / NovoCure S -5,402 1,064,094 -0.51 15.007 -81,068 15,968,859 -0.51
2017-06-13 NVCR / NovoCure S -88,700 1,069,496 -7.66 15.232 -1,351,078 16,290,563 -8.29
2017-06-12 NVCR / NovoCure S -5,100 1,158,196 -0.44 15.085 -76,934 17,471,387 -0.44
2017-06-09 NVCR / NovoCure S -175,501 1,163,296 -13.11 15.128 -2,654,979 17,598,342 -15.09
2017-02-27 NVCR / NovoCure M 342,954 1,338,797 34.44 0.17 58,302
2017-01-06 NVCR / NovoCure A 3,156 995,843 0.32 6.673 21,060
2016-04-13 NVCR / NovoCure M 59,130 992,687 6.33 0.17 10,052
2016-03-03 NVCR / NovoCure P 10,000 933,557 1.08 15.00 150,000 14,003,355 1.07
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)

Peers of Danziger Asaf include the following: Ambrogi Michael J., Burkoth William T., DOYLE WILLIAM F, FUTRELL STEVE, GRANOFF MICHAEL D, GROENHUYSEN WILHELMUS CM, HILLEMAN JERYL L, Hung David, JANIS FRANCES, Kirson Eilon D., LAVIGNE LOUIS J JR, LEUNG GABRIEL, Langloss Timothy J., Longsworth Todd Christopher, MYLOD ROBERT J JR, Madden Martin J., McCoy Sherilyn S, Melnyk Peter M., PHILLIPS CHARLES G III, Palti Yoram, Perlhagen Gert L., Pomona Associates VII, L.P., Pomona Capital VII Fund Investors, L.P., Pomona Capital VII, L.P., Pomona G.P. Holdings LLC, Pomona Secondary Associates VII LLC, Shah Pritesh, VERNON W ANTHONY, Volati Ltd, WFD Ventures Fund II, L.P., Wyss Hansjoerg, . Peers are determined by cross-linking the filings of Danziger Asaf with insider filings of others at the same companies.

Related News Stories

Buy The Dip In NovoCure

2018-08-01 seekingalpha
Figure 1: For prudent investors with cash on the sidelines, dips can be the most exciting action in stock prices. (0-2)

NovoCure (NVCR) Catches Eye: Stock Jumps 7.4%

2018-07-17 zacks
NovoCure Limited (NVCR - Free Report) was a big mover last session, as the company saw its shares rise more than 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 11.1% in the past one-month time frame.

Trade of the Day: Novocure Ltd (NVCR) | InvestorPlace

2018-07-06 investorplace
To receive further updates on this Novocure Ltd (NASDAQ:NVCR) trade as well as an alert when it’s time to take profits, sign up for a risk-free trial of Power Options Weekly today. (14-1)

Under Armour Is A Winner - Cramer's Lightning Round (6/20/18)

2018-06-21 seekingalpha
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, June 20. (55-0)

Cramer's lightning round: My favorite cybersecurity stocks

2018-06-20 cnbc
FireEye Inc.: "FireEye is good. I mean, let's go over the pecking order. I think that Proofpoint is better. I think that Palo Alto Networks – how about that huge insider buy by [new CEO] Nikesh Arora? And then, I have to tell you, I like Nice more, I like Foritnet more, I like Cyberark more and then I will endorse FireEye." (39-1)